Ciclosporin topical gel - Perioc
Latest Information Update: 19 Feb 2015
At a glance
- Originator Perioc
- Class Antineoplastics; Antipsoriatics; Antirheumatics; Ciclosporins; Eye disorder therapies; Neuroprotectants
- Mechanism of Action Cyclophilin inhibitors; Peptidylprolyl isomerase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase II Periodontitis
Most Recent Events
- 26 Jan 2015 Phase-II clinical trials in Periodontitis (Adjunctive treatment) in Sweden (Topical)